Alzheimer's Disease
Showing NaN - NaN of 79
Alzheimer's Disease, Dementia, Brain Diseases Trial in Italy, United Kingdom, United States (Donanemab, Placebo)
Not yet recruiting
- Alzheimer's Disease
- +7 more
- Donanemab
- Placebo
-
Chandler, Arizona
- +51 more
Feb 13, 2023
Alzheimer's Disease Trial in Worldwide (BIIB092, Placebo)
Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)
Active, not recruiting
- Alzheimer's Disease
- Semorinemab
- +2 more
-
Garden Grove, California
- +48 more
Sep 1, 2022
Alzheimer's Disease Trial in Worldwide (Placebo, Bepranemab)
Recruiting
- Alzheimer's Disease
- Placebo
- Bepranemab
-
Sun City, Arizona
- +115 more
Aug 18, 2022
Alzheimer's Disease Trial in United States (Remternetug (IV), Remternetug (SC), Placebo)
Recruiting
- Alzheimer's Disease
- Remternetug (IV)
- +2 more
-
Chandler, Arizona
- +70 more
Aug 10, 2022
Alzheimer's Disease Trial in Worldwide (Placebo, Gantenerumab)
Alzheimer's Disease Trial in United States (TB006, Placebo)
Active, not recruiting
- Alzheimer's Disease
- TB006
- Placebo
-
Garden Grove, California
- +17 more
May 29, 2022
Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)
Alzheimer's Disease Trial in Delray Beach, Miami (Longeveron Mesenchymal Stem Cells, Placebo)
Completed
- Alzheimer's Disease
- Longeveron Mesenchymal Stem Cells
- Placebo
-
Delray Beach, Florida
- +2 more
Dec 13, 2021
Alzheimer's Disease Trial in Worldwide (Gantenerumab, Placebo)
Cognitive Dysfunction, Alzheimer's Disease Trial in United States (Aducanumab, Placebo)
Terminated
- Cognitive Dysfunction
- Alzheimer's Disease
- Aducanumab
- Placebo
-
Phoenix, Arizona
- +21 more
Aug 19, 2021
Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)
Terminated
- Alzheimer's Disease
- Aducanumab (BIIB037)
- Placebo
-
Phoenix, Arizona
- +180 more
Aug 9, 2021
Alzheimer's Disease Trial in Worldwide (Azeliragon, Placebo)
Alzheimer's Disease Trial in Worldwide (Elenbecestat, Placebo)
Alzheimer's Disease Trial in United States (Aducanumab (recombinant, fully human anti-Aß IgG1 mAb), Placebo)
Terminated
- Alzheimer's Disease
- Aducanumab (recombinant, fully human anti-Aβ IgG1 mAb)
- Placebo
-
Tucson, Arizona
- +31 more
Jul 31, 2020
Alzheimer's Disease Trial in Worldwide (Crenezumab, Placebo)
Alzheimer's Disease Trial in Worldwide (Crenezumab)
Terminated
- Alzheimer's Disease
-
Newport Beach, California
- +65 more
Jun 25, 2020